Home >Products> Spectrum | HPLC | GC | MS >HPLC / FPLC > Sepax Glycomix SAX Columns
Spectrum | HPLC | GC | MS:  Spectrophotometers   HPLC / FPLC   Gas Chromatograph   Mass Spectrometers   Gas Generator Systems   Ultraviolet Detectors  
Sepax Glycomix SAX Columns
Sepax Glycomix SAX Columns
Place of Origin:
United States
Brand:
Sepax Technologies, Inc.
Model:
Price:
Hits:
1472 
Updated:
4/1/2013
  • Product Detail
  • Company Profile

    Description

    Glycomix™ strong anion-exchange phase is made of narrow-dispersed and hydrophilic polymer particles. It is a strong anion exchanger with quaternary ammonium functional groups that are chemically bonded to the hydrophilic surface of the polymer particles.

    Packing

    Chemical composition of Glycomix™ SAX

     

     

    Glycomix™ SAX Technical Specifications

    Characteristics Glycomix™ SAX
    Functional Group Quaternary ammonium
    Surface characteristics Hydrophilic
    pH range 2 - 12
    Typical backpressure for 4.6×250 mm 10 bar for 0.22 mL/min
    38 bar for 1 mL/min
    Maximum backpressure ~ 1,500 (psi)
    Salt concentration range 20 mM - 2.0 M
    Maximum temperature ~ 80 (°C)
    Mobile phase compatibility Aqueous and organic
    Applications Heparin, highly charged polysaccharides

     

     


     

    Characteristic

    Featured Characteristics

    • High capacity and high resolution
    • High lot-to-lot reproducibility
    • Wide pH range (2-12)
    • From analytical to preparative scale
    • Ideal for separation and analysis of heparin, glycans

     

     

     

     

     

    High Lot to lot Reproducibility

    With well-controlled surface chemistry and resin production, Glycomix resins exhibit high lot to lot reproducibility which leads to consistent column performance. The separation variation for Heparin from batch to batch is less than 1% for retention time and 5% for the peak area.

     

    Figure 2. High Lot-to-lot reproducibility of three lots of Glycomix™ SAX resins.

    Conditions  
    Column: Glycomix™ SAX, 4.6×250mm
    Mobile phase: A: 0.04% NaH2PO4, pH 3.0
    B: 0.04% NaH2PO4+14% NaClO4, pH 3.0
    Flow rate: 0.22 mL/min
    Gradient: 20% - 90% B in 60 minutes
    Wavelength: 202 nm
    Temperature: 25 °C
    Injection volume: 10 µL
    Pressure: 9.5 bar
    Sample: 20 mg/mL Heparin sodium
    1 mg/mL Dermatan sulfate (DS)
    1 mg/mL Oversulfated chondroitin sulfate (OSCS) in H2O

     

    Lot-to-Lot peak retention time relative standard deviation.

    Peak Name Lot A Lot B Lot C RSD%
    Chondroitin Sulfate B 12.286 12.300 12.434 0.41%
    Heparin 21.71 21.723 21.919 0.44%
    OSCS 33.936 33.853 34.114 0.32%

    Long column life time

    Glycomix™ SAX has long column life time due to its resin surface chemistry and stable manufacturing process. Figure below exhibits one column's performance for duplicated injections. The column shows consistent separation efficiency.

     

    Figure 3. Chromatogram overlays of duplicated injections.

    Conditions  
    Column: Glycomix™ SAX, 4.6×250mm
    Guard Column: Glycomix™ SAX, 4.6×50mm
    Mobile phase: A: 0.04% NaH2PO4, pH 3.0
    B: 0.04% NaH2PO4+14% NaClO4, pH 3.0
    Flow rate: 0.22 mL/min
    Gradient: 20% - 90% B in 60 minutes
    Wavelength: 202 nm
    Temperature: 25 °C
    Injection volume: 10 µL
    Pressure: 9.5 bar
    Sample: 20 mg/mL Heparin sodium
    1 mg/mL Dermatan sulfate (DS)
    1 mg/mL Oversulfated chondroitin sulfate (OSCS) in H2O

    Sensitive separation of different Heparin loading

    Glycomix™ SAX is able to separate components from commercially available standards. In Figure 4, Panel A shows the standard run with 20mg/mL Heparin, 1mg/mL DS and 1 mg/mL OSCS. Panel B is the OSCS chromatogram with 1 mg/mL concentration. In comparison to Panel B, the small peak between DS and Heparin comes from the standard OSCS sample. Column running conditions are the same as for Figure 3.

    Glycomix™ SAX can be used in the quantitative analysis of Heparin and its impurities. Figure 5 shows the different heparin loadings over concentration range from 0.5 mg/ml to 10 mg/ml, 0.125 mg/ml to 4 mg/ml for OSCS and 0.25 mg/ml to 4 mg/ml for DS. The R2 values for both standards exceed 0.99 in the tested concentration range.

     

    Figure 4. Chromatogram overlays of OSCS standard and Heparin with DS and OSCS.

     

    Figure 5. Chromatogram overlays of different heparin injections from 0.5mg/mL to 10mg/mL concentration, DS from 0.125 mg/mL to 4.0 mg/mL and OSCS from 0.25 mg/mL to 4.0 mg/mL.

     

    Conditions  
    Column: Glycomix™ SAX, 4.6×250mm
    Guard Column: Glycomix™ SAX, 4.6×50mm
    Mobile phase: A: 0.04% NaH2PO4, pH 3.0
    B: 0.04% NaH2PO4+14% NaClO4, pH 3.0
    Flow rate: 0.22 mL/min
    Gradient: 20% - 90% B in 60 minutes
    Wavelength: 202 nm
    Temperature: 25 °C
    Injection volume: 10 µL
    Pressure: 9.5 bar
    Sample: 20 mg/mL Heparin sodium
    1 mg/mL Dermatan sulfate (DS)
    1 mg/mL Oversulfated chondroitin sulfate (OSCS) in H2O

    Column Performance Comparison

    In comparison, Glycomix™ SAX performs superior to Dionex's column for heparin separation.1,2 Figure 7 shows the chromatogram of Heparin separation from Glycomix™ SAX. The resolutions are 3.8 between DS and heparin, 5.8 between heparin and OSCS. The U.S. Pharmacopeia (USP) requirements for the separation for DS/ heparin are 1.0 and 1.5 for OSCS /heparin3. GlycomixTM SAX has a much better separation resolution than USP's requirement. In Dionex's application note, Dionex IonPac AG11 guard with AS11 analytical column gives a 1.1 and 1.8 resolution for DS/heparin and heparin/OSCS respectively.

    Figure 7. Heparin Sodium, Chondriotin Sulfate B, and Oversulfated Chondroitin Sulfate separation on Glycomix™ SAX.

    Conditions  
    Column: Glycomix™ SAX, 4.6×250mm
    Guard Column: Glycomix™ SAX, 4.6×50mm
    Mobile phase: A: 0.04% NaH2PO4, pH 3.0
    B: 0.04% NaH2PO4+14% NaClO4, pH 3.0
    Flow rate: 0.22 mL/min
    Gradient: 20% - 90% B in 60 minutes
    Wavelength: 202 nm
    Temperature: 25 °C
    Injection volume: 10 µL
    Pressure: 10 bar
    Sample: 20 mg/mL Heparin Sodium
    0.2 mg/mL Dermatan Sulfate (DS)
    0.2 mg/mL Oversulfated Chondroitin Sulfate (OSCS)

    bio-equip.cn
    Profile

    Sepax Technologies, Inc., a privately held company, was founded in Delaware, USA in November 2002. It develops and manufactures HPLC consumables, bulk media, and equipment in liquid chromatography for chemical and biological separations. It is a fast growing technology company and owns patents, proprietary technologies and know-how. Sepax has emerged as a leader in the biological separation industry in the global market.
    Business strategies

    Sepax Technologies, Inc. develops innovative HPLC consumables, bulk media, and instruments to solve separation challenges in the global market. We provide solution-based products by closely working with our customer scientists in pharmaceuticals, biopharmaceuticals, research institutes and government labs. Our strong technical team develops various methods with our customers to analyze complex biological molecules. As a leader in the biological separation industry, we constantly develop the best bio-separation technologies and products for our global customers. We have reached a competitive position globally in fast growing regions.
    Vision Statement

    To become a technology leader in the biological separation industry in the global market and provide solution based products and services for our customers.
    Operation

    Sepax Technologies, Inc.
    Our company headquarter in Delaware is located in Delaware Technology Park with facilities of 15,000 ft2 dedicated to the development of separation resin technologies and instrumentation, production of HPLC resins, columns and CE consumables. It is also the marketing and sales center for our US and global markets.


    Sales
    Domestic
    Audrey Fisher
    Field Sales Account Manager
    (Northern CA areas, UT, CO, OR)
    Direct Phone: 925-324-5223
    Email: afisher@sepax-tech.com
    Kathleen Falls
    West Coast Regional Manager
    (All other CA areas, WA, TX, AZ, NM, MI)
    Direct Phone: 323-228-0004
    Email: kfalls@sepax-tech.com
    Michael Hunnewell
    Field Sales Account Manager
    (MA, RI, NH, CT, NY)
    Direct Phone: 302-650-3955
    Email: mhunnewell@sepax-tech.com
    Colleen Callahan
    Midwest Account Manager
    (WI, IL, IN, OH, MO)
    Direct Phone: 302-366-1101, ext 106
    Cell Phone: 302-339-8747
    Email: ccallahan@sepax-tech.com
    All other areas, please contact
    Helen Gu
    Vice President, Sales
    Direct phone: 302-650-3909
    Email: hgu@sepax-tech.com
    International
    Tingting Wu
    Executive Account Manager/Marketing
    Phone: 302-366-1101, ext 115
    Email: twu@sepax-tech.com
Request Information
Request Information: yes no
Request Quotation: yes no
refresh

I agree to share my inquiry with the other matching suppliers.

Request Information

* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Postcode:
Institution/Company:
Address:
* Country:
Request Information:
yes no
Request Quotation:
yes no
* Message:
* Verification Code:
refresh
I agree to share my inquiry to the other matching suppliers.